Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Limited inhibition of multiple nodes in a driver network blocks metastasis.
Loss of CD73 shifts transforming growth factor-ß1 (TGF-ß1) from tumor suppressor to promoter in endometrial cancer.
Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes.
FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2. FASEB J. 2013 Apr; 27(4):1439-49.
View in:
PubMed
subject areas
Angiotensin II
Animals
Cardiomegaly
Fibrosis
Heart
LIM-Homeodomain Proteins
Male
Mice
Mice, Knockout
Mitogen-Activated Protein Kinases
Muscle Proteins
Myocytes, Cardiac
rho-Associated Kinases
Transcription Factors
Up-Regulation
authors with profiles
James Liao